XML 50 R39.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Sale of Pelican Business and Investment in Primrose Bio - Narrative (Details)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 18, 2023
USD ($)
position
shares
Mar. 31, 2024
USD ($)
Mar. 31, 2023
USD ($)
Dec. 31, 2023
USD ($)
Jan. 01, 2025
USD ($)
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Derivative assets with fair value $ 3,200        
Derivative Asset Noncurrent, Statement Of Financial Position, Extensible Enumeration, Not Disclosed Flag condensed consolidated balance sheet        
Gain on derivative instruments   $ 196 $ 0    
Net loss from discontinued operations   0 $ 1,665    
Primordial Genetics          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Number of contracts | position 2        
Primrose Bio          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Consideration paid for an interest in potential development milestone $ 15,000        
Interest in potential development milestone (as a percent) 50.00%        
Primrose Bio | PeliCRM197 | Forecast          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Sales revenue milestone         $ 3,000
Primrose Bio | Below 3 million | PeliCRM197 | Forecast          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Interest in sales revenue (as a percent)         25.00%
Primrose Bio | Above 3 million | PeliCRM197 | Forecast          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Interest in sales revenue (as a percent)         35.00%
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Pelican Technology Holdings, Inc.          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Consideration paid for an interest in potential development milestone $ 15,000        
Goodwill written off       $ 4,100  
Gain on sale of Pelican       $ 2,100  
Business exit costs $ 1,200        
Net loss from discontinued operations   $ 2,400      
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Pelican Technology Holdings, Inc. | Restricted Stock Awards          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Shares received as consideration (in shares) | shares 474,746        
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Pelican Technology Holdings, Inc. | Common Stock          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Shares received as consideration (in shares) | shares 2,146,957        
Disposal Group, Disposed of by Sale, Not Discontinued Operations | Pelican Technology Holdings, Inc. | Preferred Stock          
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations          
Shares received as consideration (in shares) | shares 4,278,293